His primary scientific interests are in Immunology, Internal medicine, Vasculitis, Lupus erythematosus and Autoantibody. His Immunology research incorporates themes from Disease and Pathology. His research in the fields of Rheumatology overlaps with other disciplines such as Cyclophosphamide.
The study incorporates disciplines such as Evidence-based medicine and Intensive care medicine in addition to Vasculitis. His work in Lupus erythematosus addresses subjects such as Lupus nephritis, which are connected to disciplines such as Immunopathology. While the research belongs to areas of Gastroenterology, Cees G. M. Kallenberg spends his time largely on the problem of Rituximab, intersecting his research to questions surrounding Randomized controlled trial.
Immunology, Internal medicine, Vasculitis, Anti-neutrophil cytoplasmic antibody and Pathology are his primary areas of study. His is involved in several facets of Immunology study, as is seen by his studies on Autoantibody, Proteinase 3, Lupus erythematosus, Antibody and Pathogenesis. When carried out as part of a general Internal medicine research project, his work on Rheumatology is frequently linked to work in Cyclophosphamide, therefore connecting diverse disciplines of study.
His Rituximab research extends to the thematically linked field of Vasculitis. His work investigates the relationship between Pathology and topics such as Glomerulonephritis that intersect with problems in Renal function. His research investigates the link between Microscopic polyangiitis and topics such as Granulomatosis with polyangiitis that cross with problems in Wegener s and Rheumatism.
His primary areas of study are Vasculitis, Immunology, Internal medicine, Anti-neutrophil cytoplasmic antibody and Gastroenterology. His work on Granulomatosis with polyangiitis, Birmingham Vasculitis Activity Score and Microscopic polyangiitis as part of general Vasculitis study is frequently linked to Univariate analysis, bridging the gap between disciplines. Cees G. M. Kallenberg regularly ties together related areas like Disease in his Immunology studies.
His biological study spans a wide range of topics, including Magnetic resonance imaging and Cardiology. His Anti-neutrophil cytoplasmic antibody research is multidisciplinary, relying on both Body mass index, Randomized controlled trial, Virology and Proteinase 3. His Gastroenterology study incorporates themes from Biomarker, Interleukin 6, Azathioprine and Giant cell arteritis.
His scientific interests lie mostly in Immunology, Vasculitis, Anti-neutrophil cytoplasmic antibody, Internal medicine and Gastroenterology. His Immunology research incorporates elements of Salivary gland and Disease. His research in Vasculitis is mostly focused on Systemic vasculitis.
His Anti-neutrophil cytoplasmic antibody research focuses on Proteinase 3 and how it relates to Microscopic polyangiitis, Granulomatosis with polyangiitis, Whole blood, Gene signature and Peripheral blood mononuclear cell. Cees G. M. Kallenberg has researched Gastroenterology in several fields, including Azathioprine and Rituximab. His Birmingham Vasculitis Activity Score research is multidisciplinary, incorporating perspectives in Surgery and Prednisone.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
John H. Stone;Peter A. Merkel;Robert Spiera;Philip Seo.
The New England Journal of Medicine (2010)
EULAR Recommendations for the management of primary small and medium vessel vasculitis
C. Mukhtyar;L. Guillevin;M. C. Cid;B. Dasgupta.
Annals of the Rheumatic Diseases (2009)
Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
George K Bertsias;Maria Tektonidou;Zahir Amoura;Martin Aringer.
Annals of the Rheumatic Diseases (2012)
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
S van Assen;N Agmon-Levin;O Elkayam;R Cervera.
Annals of the Rheumatic Diseases (2011)
Efficacy of Remission-Induction Regimens for ANCA-associated Vasculitis
Ulrich Specks;Peter A. Merkel;Philip Seo;Robert Spiera.
The New England Journal of Medicine (2013)
Association Between Active Wegener's Granulomatosis and Anticytoplasmic Antibodies
J. W. C. Tervaert;F. J. Van Der Woude;A. S. Fauci;J. L. Ambrus.
JAMA Internal Medicine (1989)
Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential.
Cees G.M. Kallenberg;Elisabeth Brouwer;Jan J. Weening;Jan W. Cohen Tervaert.
Kidney International (1994)
Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study.
M. M. Boomsma;C. A. Stegeman;M. J. Van Der Leij;W. Oost.
Arthritis & Rheumatism (2000)
Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial.
J. M. Meijer;P. M. Meiners;A. Vissink;F. K. L. Spijkervet.
Arthritis & Rheumatism (2010)
Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils.
R. Goldschmeding;C. E. Van Der Schoot;D. Ten Bokkel Huinink;C. E. Hack.
Journal of Clinical Investigation (1989)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: